Preferential topography of proteins regulating vascularization and apoptosis in a MX1 xenotransplant after treatment with hypoxia, hyperthermia, ifosfamide, and irradiation

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 25, Issue 4, 2002, Pages 325-336

  Schmitt, Oliver ^a   Schubert, Christine ^a   Feyerabend, Thomas ^a   Hellwig Bürgel, Thomas ^a   Weiss, Christoph ^a   Kühnel, Wolfgang ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Human breast carcinoma; Hyperthermia; Hypoxia; Ifosfamide; Immunohistochemistry; Irradiation; Nu nu mice; Xenotransplant

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CELL ADHESION MOLECULE; FAS ANTIGEN; IFOSFAMIDE; PROTEIN BCL 2; PROTEIN P53; SCLEROPROTEIN; SOMATOSTATIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CARCINOMA; CELL ULTRASTRUCTURE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HYPERTHERMIC THERAPY; HYPOXIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MOUSE; NONHUMAN; ONCOGENE C MYC; OXYGEN TISSUE LEVEL; PROTEIN EXPRESSION; TUMOR VASCULARIZATION; XENOGRAFT;

ANIMALS; ANOXIA; ANTINEOPLASTIC AGENTS, ALKYLATING; APOPTOSIS; BREAST NEOPLASMS; CELL ADHESION MOLECULES; COMBINED MODALITY THERAPY; CYTOKINES; ENDOTHELIAL GROWTH FACTORS; ENDOTHELINS; EXTRACELLULAR MATRIX PROTEINS; FACTOR VIII; FEMALE; HYPERTHERMIA, INDUCED; IFOSFAMIDE; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; MICE; MICE, NUDE; NEOVASCULARIZATION, PATHOLOGIC; NERVE GROWTH FACTOR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 0036338441     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200208000-00001     Document Type: Article

References (86)

1. Radiation therapy and hyperthermia improve the oxygenation of human soft tissue sarcomas
2. Local hyperthermia, radiation, and chemotherapy in locally advanced malignancies
3. Local hyperthermia, hyperfractionated radiation, and cisplatin in preirradiated recurrent lymph node metastases of recurrent head and neck cancer
4. Ifosfamide and carboplatin combined with 41.8°C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma
5. Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8°C whole body hyperthermia in patients with refractory sarcoma: A phase II study
6. Klinische studien zur kombination von ifosfamid, carboplatin und etoposid (ICE) mit 41.8°C ganzkörperhyperthermie
7. Systematic hyperthermia and ICE chemotherapy for sarcoma patients: Rationale and clinical status
8. Hyperthermia as an adjuvant to radiotherapy in the treatment of malignant melanoma
9. 2 in well oxygenated xenotransplanted human sarcoma
10. Stereologic evaluation of the vasculature in a MX1 xenotransplanted tumour model after combinations of treatment with ifosfamide, hyperthermia and irradiation
11. Radiation-induced apoptosis in normal and pre-neoplastic mammary glands in vivo: Significance of gland differentiation and p53 status
12. Radiation-induced micronuclei formation in human breast cancer cells: Dependence on serum and cell cycle distribution
13. p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs
14. Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells
15. Molecular aspects of breast and ovarian cancer
16. Induction of the death-promoting gene bax-alpha sensitizes cultured breast-cancer cells to drug-induced apoptosis
17. Long-duration, mild whole body hyperthermia with cisplatin: Tumour response and kinetics of apoptosis and necrosis in a metastatic rat mammary adenocarcinoma
18. APO2.7 defines a shared apoptotic-necrotic pathway in a breast tumor hypoxia model
19. Pentoxifylline inhibits hypoxia-induced upregulation of tumor cell tissue factor and vascular endothelial growth factor
20. Thymus dysgenesis in nude (nu nu) mice
21. Antitumor activity of cis-dichlorodiammineplatinum(II)
22. 2 and pH during thermochemotherapy in xeno-transplanted human tumors growing in nude mice
23. Effects of temperature on the therapeutic efficacy and pharmacokinetics of ifosfamide
24. Metabolism and pharmacokinetics of oral and intravenous ifosfamide
25. Characterization and quantitative estimation of activated cyclophosphomide in blood and urine
26. Dechlorethylation of ifosfamide and neurotoxicity
27. The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and in vivo
28. The use of lead citrate at high pH as an electronopaque stain in electron microscopy
29. Immunocytochemical colocalization of adhesive proteins with clathrin in human blood platelets: Further evidence for coated vesicle-mediated transport of von Willebrand factor, fibrinogen and fibronectin
30. Tumor angiogenesis
31. Stimulatory interaction between vascular endothelial growth factor and endothelin-1 on each gene expression
32. Biological activities of fibroblast growth factors
33. Structural characterization and biological functions of fibroblast growth factor
34. In vitro angiogenesis on the human amniotic membrane: Requirement for basic fibroblast growth factor-induced proteinases
35. Basic fibroblast growth factor suppresses tissue plasminogen activator release from cultured human umbilical vein endothelial cells but enhances that from cultured human aortic endothelial cells
36. Hypoxia-induced bFGF gene expression is mediated through the JNK signal transduction pathway
37. Candidate genes for the hypoxic tumor phenotype
38. Purification and properties of an endothelial cell growth factor from human platelets
39. Localization of platelet-derived endothelial cell growth factor in human placenta and purification of an alternatively processed form
40. Identification of angiogenic activity and the coning and expression of platelet-derived endothelial cell growth factor
41. Examining the technique of angiogenesis assessment in invasive breast cancer
42. Tissue transglutaminase expression in human breast cancer
43. Angiogenesis as a predictor of long-term survival for patients with node-negative breast cancer
44. Comparison of different immunohistochemical methods in the assessment of angiogenesis: Lack of prognostic value in a group of 77 selected node-negative breast carcinomas
45. Heterogeneity and reproducibility of microvessel counts in breast cancer
46. The basement membrane and its involvement in carcinoma cell invasion
47. Regulation of human interstitial collagenase (matrix metalloproteinase-1) promoter activity by fibroblast growth factor
48. Fibroblast growth factor stimulates the gene expression and production of tissue inhibitor of metalloproteinase-1 in bovine granulosa cells
49. Correlation of cell migration, cell invasion, receptor number, proteinase production, and basic fibroblast growth factor levels in endothelial cells
50. p53: DNA damage, DNA repair, and apoptosis
51. Complex formation between p53 and replication protein A inhibits the sequence-specific DNA binding of p53 and is regulated by single-stranded DNA
52. Bcl-2 and apoptosis in lymph node positive breast carcinoma
53. Induction of apoptosis in fibroblasts by c-myc protein
54. Fas expression and function in normal and malignant breast cell lines
55. Induction of wild-type p53, Bax, and acidic endonuclease during somatostatin-signaled apoptosis in MCF-7 human breast cancer cells
56. Immunohistochemical and ultrastructural studies on the sinusoidal lining cells of canine hepatocellular carcinoma
57. Hepatoblastoma in a dog
58. Ultrastructural study of micro-blood vessels in human brain tumors and peritumoral tissue
59. Vascular structures in brain tumors
60. The morphology of xenotransplanted human breast carcinoma MX1 growing in nude mice. A light and transmission electron microscopic study
61. Alterations of the nucleolar organiser regions (AgNORs) in the human MX1 xenograft after thermochemotherapy as detected by automatic image analysis
62. The effect of ifosfamide on tumor oxygenation at different temperature
63. Epidemiological and biochemical support for a theory on the cause and prevention of breast cancer
64. Oxygen regulated VEGF gene expression in the human breast cancer cell line MX1 in vitro and in vivo
65. Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1
66. Breast cancer angiogenesis-new approaches to therapy via antiangiogenesis, hypoxic activated drugs, and vascular targeting
67. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: Angiogenic implications for signal transduction therapy of solid tumors
68. Fibroblast growth factors: From genes to clinical applications
69. Basic fibroblast growth factor modulates integrin expression in microvascular endothelial cells
70. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo
71. Neovasculature induced by vascular endothelial growth factor is fenestrated
72. Vascular endothelial growth factor induces endothelial fenestrations in vitro
73. Activation and suppression of fibroblast function
74. Spatial organization of extracellular matrix and fibroblast activity: Effects of serum, transforming growth factor beta, and fibronectin
75. Kinetic and physical studies of cell death induced by chemotherapeutic agents or hyperthermia
76. The morphologic categorization of cell death induced by mild hyperthermia and comparison with death induced by ionizing radiation and cytotoxic drugs
77. Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia
78. Apoptosis in human adenocarcinoma HT29 cells induced by exposure to hypoxia
79. Bcl-2 protein expression and long-term survival in breast cancer
80. Resistance to APO-1 (CD95) induced apoptosis in T-ALL is determined by a BCL-2 independent antiapoptotic program
81. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 protooncogene expression in human breast cancer cells
82. Immunocytochemical demonstration of tissue transglutaminase indicative of programmed cell death (apoptosis) in hormone sensitive mammary tumours